U.K. Viagra Reimbursement Extended To All Prostate Cancer Patients
Executive Summary
The U.K.' s National Health Service proposed regulations covering reimbursement for Pfizer's Viagra and other erectile dysfunction therapies have been expanded to include all patients being treated for prostate cancer, the Department of Health reported in a May 7 statement.
You may also be interested in...
Glaxo Decides Not To Pursue U.K. Flu Awareness Campaign For Relenza
The potential negative impact on the U.K.' s National Health Service drug budget may be one factor behind Glaxo Wellcome's decision not to launch a flu awareness campaign for its neuraminidase inhibitor Relenza (zanamivir) in the U.K.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011